Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from FIGS ( (FIGS) ).
On August 7, 2025, FIGS, Inc. released its second quarter 2025 financial results, reporting a 5.8% increase in net revenues to $152.6 million, driven by higher order values and increased customer orders. The company achieved a net income margin of 4.7% and an adjusted EBITDA margin of 12.9%, surpassing expectations on both top and bottom lines. Despite a slight decrease in gross margin due to higher inventory reserves and tariffs, FIGS reduced operating expenses by 3.5% year over year. The company also saw a 4.1% increase in active customers, reflecting strong demand and strategic marketing efforts. FIGS raised its full-year 2025 financial outlook, citing confidence in its core business growth and cost mitigation strategies.
The most recent analyst rating on (FIGS) stock is a Buy with a $7.25 price target. To see the full list of analyst forecasts on FIGS stock, see the FIGS Stock Forecast page.
Spark’s Take on FIGS Stock
According to Spark, TipRanks’ AI Analyst, FIGS is a Outperform.
FIGS scores well due to a strong financial foundation and positive technical momentum. However, overvaluation concerns and macroeconomic challenges from tariffs weigh on the score. Earnings call insights show growth potential but highlight significant risks that need addressing.
To see Spark’s full report on FIGS stock, click here.
More about FIGS
FIGS, Inc. is a leading global healthcare apparel brand focused on enhancing the lives of healthcare professionals. The company specializes in producing high-quality scrubwear and other healthcare-related apparel, catering primarily to the needs of medical professionals.
Average Trading Volume: 2,078,320
Technical Sentiment Signal: Buy
Current Market Cap: $1B
Find detailed analytics on FIGS stock on TipRanks’ Stock Analysis page.